Spyre Therapeutics, Inc. (3920)
Market Closed
17 Jul, 20:00
XFRA 
€
81. 50
-7.5
-8.427%
€
681.91M Market Cap
- P/E Ratio
- Div Yield
121 Volume
- Eps
€ 89
Previous Close Want to track 3920 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3920 Earnings Reports FAQ
What is the earnings per share (EPS) for 3920?
EPS data for 3920 is currently not available, as Spyre Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Spyre Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Spyre Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Spyre Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 3920 at this time, as Spyre Therapeutics, Inc has no recent EPS data to calculate it.
